Advertisement
ARKG vs IHI
Which ETF would AI Choose? ARK Genomic Revolution ETF (ARKG) vs. iShares U.S. Medical Devices ETF (IHI)
Key Takeaways
- ARKG is an actively managed thematic ETF targeting genomics and biotechnology innovation, while IHI is a passive ETF providing targeted exposure to U.S. medical device and equipment companies.
- ARK Genomic Revolution ETF (ARKG) maintains a concentrated portfolio of approximately 32 holdings with an expense ratio of 0.75%, emphasizing high-conviction positions in gene editing and diagnostics firms.
- iShares U.S. Medical Devices ETF (IHI) tracks an index with roughly 45-51 holdings and a lower expense ratio of 0.37%, offering broader diversification within the medical devices sector.
- Sector exposure differs markedly: ARKG focuses on genomics and biotechnology sub-themes within healthcare, whereas IHI concentrates exclusively on medical equipment and devices manufacturers and distributors.
- Structural differences include active management and higher turnover in ARKG versus quarterly rebalancing in the passive IHI strategy, influencing risk profiles and cost efficiency.
- Both ETFs operate within the healthcare sector but serve distinct investor objectives, with ARKG suited for thematic growth exposure and IHI for established device industry participation.
Introduction
Investors seeking healthcare sector exposure often evaluate specialized exchange-traded funds (ETFs) that address different aspects of medical innovation and equipment. ARK Genomic Revolution ETF (ARKG) and iShares U.S. Medical Devices ETF (IHI) do not compete directly but provide alternative strategies within the broader healthcare universe. ARKG pursues an active thematic approach centered on genomic technologies, while IHI delivers passive exposure to medical devices. This comparison highlights structural distinctions, exposure profiles, and positioning considerations relevant amid ongoing advancements in biotechnology and healthcare infrastructure.
ARK Genomic Revolution ETF (ARKG) Overview
ARK Genomic Revolution ETF (ARKG) is an actively managed ETF launched in 2014 that seeks long-term capital growth by investing primarily in equity securities of companies involved in the genomics revolution. The fund holds approximately 32 positions and allocates heavily to healthcare, with top holdings including 10x Genomics Inc (TXG), Twist Bioscience Corp (TWST), Tempus AI Inc (TEM), CRISPR Therapeutics AG (CRSP), and Illumina Inc (ILMN). Its expense ratio stands at 0.75%. The strategy emphasizes innovative areas such as gene editing, molecular diagnostics, and bioinformatics, resulting in a concentrated, high-conviction portfolio without a specific index benchmark.
iShares U.S. Medical Devices ETF (IHI) Overview
iShares U.S. Medical Devices ETF (IHI) is a passive ETF launched in 2006 that seeks to track the performance of the Dow Jones U.S. Select Medical Equipment Index. The fund holds approximately 45-51 securities focused exclusively on U.S. medical device and equipment companies. Top holdings typically include Abbott Laboratories (ABT), Intuitive Surgical Inc (ISRG), Medtronic PLC (MDT), Stryker Corp (SYK), and Becton Dickinson and Co (BDX). Its expense ratio is 0.37%. The strategy employs quarterly rebalancing to maintain index alignment, providing diversified exposure within the healthcare equipment subsector.
Industry and Thematic Backdrop
The healthcare sector encompasses distinct sub-industries, including biotechnology, genomics, and medical devices, each influenced by regulatory approvals, technological advancements, reimbursement policies, and demographic trends such as aging populations. Medical device manufacturers benefit from steady demand for diagnostic and therapeutic equipment, while genomics firms face higher volatility tied to clinical trial outcomes and innovation cycles. Macroeconomic factors including interest rate environments and healthcare spending patterns affect capital flows across both areas. Regulatory developments in the United States and globally continue to shape innovation timelines and market access for companies in these fields.
Performance and Positioning Comparison
Over recent market cycles, ARK Genomic Revolution ETF (ARKG) has exhibited higher volatility consistent with its active thematic focus on emerging genomics technologies, with performance driven by individual company developments in gene editing and diagnostics. In contrast, iShares U.S. Medical Devices ETF (IHI) has demonstrated more stable behavior linked to established medical equipment leaders, benefiting from consistent revenue streams in device manufacturing. Relative positioning reflects differences in risk exposure, with ARKG offering greater sensitivity to biotechnology breakthroughs and IHI providing steadier participation in healthcare infrastructure trends. Both ETFs respond to sector rotation patterns and broader healthcare spending dynamics across multiple quarters.
AI Screener
Tickeron’s AI Screener is an AI-powered stock and ETF discovery tool that helps traders and investors filter the market based on technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs using customizable filters such as industry, market capitalization, technical indicators, price patterns, and performance metrics. The screener helps identify trade ideas, trending stocks, breakout candidates, and market opportunities more efficiently than manual screening. Investors seeking data-driven insights into ETFs like ARK Genomic Revolution ETF (ARKG) or iShares U.S. Medical Devices ETF (IHI) may find the platform useful for refining their research process.
Tickeron AI Verdict
Based on structural characteristics including lower expense ratio, passive indexing methodology, broader holdings diversification within a stable subsector, and consistent liquidity profile, Tickeron’s AI would currently assign a higher probability of favor to iShares U.S. Medical Devices ETF (IHI) for investors prioritizing cost efficiency and sector stability over high-conviction thematic exposure. ARK Genomic Revolution ETF (ARKG) may appeal in environments emphasizing genomics innovation momentum, though its active management and higher fees introduce additional considerations for risk-adjusted positioning.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARKG is a Hold and IHI is a StrongBuy.
ARKG's MACD Histogram just turned positive
The Moving Average Convergence Divergence (MACD) for ARKG turned positive on October 28, 2026. Looking at past instances where ARKG's MACD turned positive, the stock continued to rise in 47 of 51 cases over the following month. The odds of a continued upward trend are 90%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 27, 2026. You may want to consider a long position or call options on ARKG as a result. In 72 of 84 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 86%.
ARKG moved above its 50-day moving average on October 27, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for ARKG crossed bullishly above the 50-day moving average on October 29, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 22 of 23 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 90%.
Following a +6.70% 3-day Advance, the price is estimated to grow further. Considering data from situations where ARKG advanced for three days, in 248 of 277 cases, the price rose further within the following month. The odds of a continued upward trend are 90%.
The Aroon Indicator entered an Uptrend today. In 202 of 220 cases where ARKG Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 90%.
Bearish Trend Analysis
The 10-day RSI Indicator for ARKG moved out of overbought territory on October 06, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 31 similar instances where the indicator moved out of overbought territory. In 28 of the 31 cases, the stock moved lower in the following days. This puts the odds of a move lower at 90%.
The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ARKG declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
ARKG broke above its upper Bollinger Band on October 27, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
IHI in upward trend: price rose above 50-day moving average on October 15, 2026
IHI moved above its 50-day moving average on October 15, 2026 date and that indicates a change from a downward trend to an upward trend. In 37 of 42 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 88%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 09, 2026. You may want to consider a long position or call options on IHI as a result. In 72 of 85 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 85%.
The Moving Average Convergence Divergence (MACD) for IHI just turned positive on October 08, 2026. Looking at past instances where IHI's MACD turned positive, the stock continued to rise in 46 of 53 cases over the following month. The odds of a continued upward trend are 87%.
The 10-day moving average for IHI crossed bullishly above the 50-day moving average on October 22, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 13 of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 87%.
Following a +2.13% 3-day Advance, the price is estimated to grow further. Considering data from situations where IHI advanced for three days, in 234 of 282 cases, the price rose further within the following month. The odds of a continued upward trend are 83%.
The Aroon Indicator entered an Uptrend today. In 238 of 292 cases where IHI Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 82%.
Bearish Trend Analysis
The 10-day RSI Indicator for IHI moved out of overbought territory on October 30, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 27 similar instances where the indicator moved out of overbought territory. In 22 of the 27 cases, the stock moved lower in the following days. This puts the odds of a move lower at 81%.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 14 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where IHI declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 84%.
IHI broke above its upper Bollinger Band on October 15, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
| ARKG | IHI | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 90% | 2 days ago 81% |
| Stochastic ODDS (%) | 2 days ago 90% | 2 days ago 81% |
| Momentum ODDS (%) | 2 days ago 86% | 2 days ago 85% |
| MACD ODDS (%) | 2 days ago 90% | 2 days ago 87% |
| TrendWeek ODDS (%) | 2 days ago 90% | 2 days ago 85% |
| TrendMonth ODDS (%) | 2 days ago 90% | 2 days ago 81% |
| Advances ODDS (%) | 3 days ago 90% | 3 days ago 83% |
| Declines ODDS (%) | 18 days ago 90% | about 1 month ago 84% |
| BollingerBands ODDS (%) | 2 days ago 90% | 2 days ago 74% |
| Aroon ODDS (%) | 2 days ago 90% | 2 days ago 82% |
Advertisement
ARKG and
Correlation & Price change
A.I.dvisor indicates that over the last year, ARKG has been loosely correlated with DNA. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if ARKG jumps, then DNA could also see price increases.
| Ticker / NAME | Correlation To ARKG | 1D Price Change % | ||
|---|---|---|---|---|
| ARKG | 100% | -6.73% | ||
| DNA - ARKG | 62% Loosely correlated | -12.01% | ||
| FATE - ARKG | 60% Loosely correlated | -4.15% | ||
| PHR - ARKG | 59% Loosely correlated | -0.72% | ||
| EDIT - ARKG | 59% Loosely correlated | -8.87% | ||
| BFLY - ARKG | 57% Loosely correlated | -14.91% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| SIO | 24.96 | 0.06 | +0.24% |
| Touchstone Strategic Income ETF (SIO) | |||
| PTNT | 24.66 | N/A | N/A |
| Corgi IP Licensing & Royalties ETF (PTNT) | |||
| WBIF | 36.54 | -0.19 | -0.53% |
| WBI BullBear Value 3000 ETF (WBIF) | |||
| IWMI | 48.89 | -0.65 | -1.31% |
| NEOS Russell 2000 High Income ETF (IWMI) | |||
| HIBL | 79.56 | -13.85 | -14.83% |
| Direxion Daily S&P 500 High Beta Bull 3X ETF (HIBL) | |||